We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

3 hedge funds and large institutions have $86K invested in Cyclo Therapeutics, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

54% less capital invested

Capital invested by funds: $188K → $86K (-$102K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
1
Calls
$38K
Puts
–
Net Calls
+$38K
Net Calls Change
-$897K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
EAM
Empery Asset Management
New York
-$1.6K
2
WVP
Worth Venture Partners
New Jersey
-$489
3
UBS Group
UBS Group
Switzerland
-$107
Name Holding Trade Value Shares
Change 		Change in
Stake
WVP
1
Worth Venture Partners
New Jersey
$54K -$489 -500 -0.7%
EAM
2
Empery Asset Management
New York
$31K -$1.6K -1,637 -3%
UBS Group
3
UBS Group
Switzerland
$1K -$107 -109 -10%

CYTHW Hedge Fund Activity: Q2 2022 in Review

3 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q2 2022, worth a combined $86K — down 54% from $188K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CYTHW and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.

The largest seller was Empery Asset Management, cutting an estimated $1.6K.

  • 3 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q2 2022, down from 4 in Q1 2022.
  • Funds reported $86K of Cyclo Therapeutics, Inc. Warrant stock for Q2 2022, down 54% quarter-over-quarter.
  • 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q2 2022 and 1 closed out, a net change of -1 holder.
  • The largest Cyclo Therapeutics, Inc. Warrant seller in Q2 2022 was Empery Asset Management, an estimated $1.6K sold.

Based on aggregated 13F filings for Q2 2022.